SCHEMBL24592398

SCHEMBL24592398

Cc1nn(CC(C)(C)c2c(F)ccc3cnn(C4CC4)c23)c2ccc(F)c(C(C)C)c12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22924152 0.89 — —
SCHEMBL25696160 0.73 HTR2A (0.33) —
SCHEMBL22328032 0.71 HTR1A (0.32) —
SCHEMBL24089579 0.67 — —
SCHEMBL24089391 0.66 HDAC4 (0.31) —
SCHEMBL25696163 0.65 EZH2 (0.35) —
SCHEMBL21662938 0.65 EZH2 (0.39) —
SCHEMBL26578040 0.63 — —
SCHEMBL22328033 0.63 EZH2 (0.35) —
SCHEMBL18408663 0.62 MAPT (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11377441-B2 Covalent inhibitors of KRAS ARAXES PHARMA LLC (US) 2022-07-05 — — US disclosed
Send feedback